ReP USP - Resultado da busca

Filtros : "Liu, Minglei" Removido: "Indexado no: Science Citation Index Expanded" Limpar

Filtros

Collaboration
Normalized affiliation
- columbia university (cu) (~1)
- instituto dante pazzanese de cardiologia (idpc) (~1)
Non normalized affiliation
- cardiovascular research center, são paulo-sp, brazil (1)
- emcor -emergências do coração, piracicaba-sp, brazil (1)
- harvard medical school, boston, massachusetts, usa (1)
- hospital agamenon magalhães, recife, pernambuco, brazil (1)
- hospital bandeirantes-são paulo-sp, brazil (1)

Artigo de periodico
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the optimize randomized trial (2013)
Feres, Fausto; Costa, Ricardo A.; Abizaid, Alexandre; Leon, Martin B.; Marin Neto , José Antonio; Botelho, Roberto V.; King, Spencer B.; Negoita, Manuela; Liu, Minglei; Paula, J. Eduardo T. de; Mangione, José A.; Meireles, George X.; Castello Júnior, Hélio J.; Nicolela Júnior, Eduardo L.; Perin, Marco A.; Devito, Fernando S.; Labrunie, André; Salvadori Júnior, Décio; Gusmão, Marcos; Staico, Rodolfo; Costa Júnior, J. Ribamar; Castro, Juliana P. de; Abizaid, Andrea S.; Bhatt, Deepak L.
Source: JAMA - Journal of The American Medical Association. Unidade: FMRP
Subjects: SÍNDROME CORONARIANA AGUDA (TERAPIA), TROMBOSE, PLAQUETAS SANGUÍNEAS, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERES, Fausto et al. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the optimize randomized trial. JAMA - Journal of The American Medical Association, v. 310, n. 23, p. 2510-2522, 2013Tradução . . Disponível em: https://doi.org/10.1001/jama.2013.282183. Acesso em: 05 nov. 2024.
APA
Feres, F., Costa, R. A., Abizaid, A., Leon, M. B., Marin Neto , J. A., Botelho, R. V., et al. (2013). Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the optimize randomized trial. JAMA - Journal of The American Medical Association, 310( 23), 2510-2522. doi:10.1001/jama.2013.282183
NLM
Feres F, Costa RA, Abizaid A, Leon MB, Marin Neto JA, Botelho RV, King SB, Negoita M, Liu M, Paula JET de, Mangione JA, Meireles GX, Castello Júnior HJ, Nicolela Júnior EL, Perin MA, Devito FS, Labrunie A, Salvadori Júnior D, Gusmão M, Staico R, Costa Júnior JR, Castro JP de, Abizaid AS, Bhatt DL. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the optimize randomized trial [Internet]. JAMA - Journal of The American Medical Association. 2013 ; 310( 23): 2510-2522.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1001/jama.2013.282183
Vancouver
Feres F, Costa RA, Abizaid A, Leon MB, Marin Neto JA, Botelho RV, King SB, Negoita M, Liu M, Paula JET de, Mangione JA, Meireles GX, Castello Júnior HJ, Nicolela Júnior EL, Perin MA, Devito FS, Labrunie A, Salvadori Júnior D, Gusmão M, Staico R, Costa Júnior JR, Castro JP de, Abizaid AS, Bhatt DL. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the optimize randomized trial [Internet]. JAMA - Journal of The American Medical Association. 2013 ; 310( 23): 2510-2522.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1001/jama.2013.282183

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024